Decision Expands Access to the Sonata® Treatment for Women Suffering from Uterine Fibroids, offering a Minimally Invasive Alternative to Hysterectomy...
This achievement highlights the health tech company’s commitment to providing healthcare accessibility for allESTERO, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE)...
Company Set to Defend Its Extensive IP Catalog for Leading Placental AllograftsMARIETTA, Ga., Dec. 17, 2024 (GLOBE NEWSWIRE) -- MiMedx...
ROCHESTER, N.Y., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company...
Fast-Growing Regional Eyecare Provider to Consolidate on Ophthalmic PlatformTAMPA, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Nextech, market leader of...
Already popular among medical practices, DoseSpot expands into dental field - software helps dental practices instantly and automatically verify patients'...
FRAMINGHAM, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Alira Health, a global healthcare consulting and technology firm transforming the patient...
Aeroflow Breastpumps won the state RFP in Montana to provide mothers under Medicaid with electric breast pumps and other maternal...
BRISBANE, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical...
Following the success of the MyWay app in the US and Germany, the partners will expand brand-oriented digital health companion...
TAMPA, FL, Dec. 17, 2024 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (the “Company”) (NASDAQ: SCNX), a specialty pharma company with...
CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled...
FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review...
SAN DIEGO, Dec. 17, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in...
YAVNE, Israel, Dec. 17, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for...
ALACHUA, Fla., December 17, 2024 – RTI Surgical ("the Company"), a leading CDMO pushing the boundaries of innovation and tissue...
Teva hosting investor call today at 8:00 a.m. ET (U.S.)Primary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD),...
Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Primary endpoints met in ulcerative colitis...
EYLEA HD demonstrated non-inferior vision gains with an every 8-week dosing regimen compared to EYLEA® (aflibercept) Injection 2 mg dosed...
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology...